Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients
Background. The most important task in the field of renal-cell cancer (RCC) treatment results improvement is the search and validation of the markers for its early diagnostics still absent in the clinical practice. It was established that even before the onset and/or detection of RCC the level of ki...
Main Authors: | E. S. Gershtein, D. S. Naberezhnov, A. A. Alferov, Svetlana D. Bezhanova, N. F. Frolova, V. B. Matveev, N. E. Kuslinskii |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-02-01
|
Series: | Onkourologiâ |
Subjects: | |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1375 |
Similar Items
-
KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients
by: K. Yu. Kanukoev, et al.
Published: (2020-11-01) -
Prognostic Value of Urinary Calprotectin, NGAL and KIM-1 in Chronic Kidney Disease
by: Felix S. Seibert, et al.
Published: (2018-08-01) -
Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases
by: Felix S. Seibert, et al.
Published: (2021-01-01) -
The importance of KIM-1 determination in tissue and urine of patients with different kidney diseases
by: Simić-Ogrizović Sanja
Published: (2010-01-01) -
Early Diagnosis in Acute Kidney Failure: Neutrophil Gelatinase Associated Lipocain (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukine-18 (IL-18), Cystatin C
by: Mehmet İlke Büget, et al.
Published: (2014-12-01)